Real-World Application of Anti-β-Amyloid Monoclonal Antibodies: Untangling Eligibility

Neurology. 2023 Nov 7;101(19):811-812. doi: 10.1212/WNL.0000000000207873. Epub 2023 Aug 16.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides*
  • Antibodies, Monoclonal
  • Humans

Substances

  • Amyloid beta-Peptides
  • Antibodies, Monoclonal